Tokyo, Japan - (Mbudzi 15, 2022) - Daiichi Sankyo (TSE: 4568) nhasi yakazivisa kuti muyedzo yekuongorora kushanda uye kuchengetedzeka kwekudzivirira kwebooster neDS-5670, mushonga weMRNA kurwisa chirwere chinotapukira checonavirus (COVID-5670). -19) ichigadzirwa naDaiichi Sankyo (pano, booster vaccination test), iyo yekutanga yekupedzisira yakawanikwa.Muyedzo wekudzivirira webooster waisanganisira vangangosvika zviuru zvishanu vechiJapan vakura vane hutano uye vakwegura zvidzidzo vakange vapedza yekutanga nhevedzano (madhasi maviri) emishonga yeMRNA yakabvumidzwa muJapan ingangoita mwedzi mitanhatu vasati vanyoreswa.Muna Ndira 2022, muyedzo wakatangwa sechikamu 1/2/3 muyedzo kuti uongorore kushanda uye kuchengetedzeka kwekudzivirira kwebooster neDS-5670 uchishandisa mishonga yemRNA yakabvumidzwa muJapan sekutonga.GMFR ye neutralizing antibody titer inopesana neSARS-CoV-2 (yekutanga dhiri) muropa mavhiki mana mushure mekuvharirwa kwebooster, mhedziso yekutanga yeyedzo yekudzivirira yebooster, yakaratidza data repamusoro uye kusadzikira kweDS-5670 kune iyo mRNA vaccine. yepakutanga strain) yakabvumidzwa muJapan, ichizadzisa chinangwa chakatarisirwa.Hapana chekuchengetedza zvakaonekwa.Tsananguro yemhedzisiro yekuyedzwa kwebooster vaccination ichaunzwa kumisangano yezvidzidzo uye mumapepa etsvagiridzo.Zvichienderana nemhedzisiro yemuyedzo, Daiichi Sankyo achaenderera mberi nekugadzirira kushandiswa kwemushonga mutsva wemRNA vaccine muna Ndira 2023. Pamusoro pezvo, Daiichi Sankyo arikuronga kuitisa miedzo yekiriniki yemajekiseni maviri emhando yepakutanga uye Omicron strains kurwisa coronavirus itsva, izvo zvinoramba zvichichinja.Daiichi Sankyo achaedza kusimbisa iyo mRNA vaccine yekuvandudza uye hurongwa hwekugadzira kuti ive nechokwadi chekuwanikwa kwakagadzikana munguva dzakajairwa uye nekukasira kupihwa kwekudzivirira kana pakaitika zvirwere zvinotapukira uye zvinotapukira.
Nezve DS-5670 DS-5670 mushonga wemRNA wekurwisa COVID-19 uchishandisa novel nucleic acid yekuburitsa tekinoroji yakawanikwa naDaiichi Sankyo, yakagadzirirwa kugadzira masoja ekudzivirira chirwere anopokana neiyo receptor binding domain (RBD) yespike protein yenovel coronavirus, uye nekudaro. inotarisirwa kuve nekudzivirira kunodiwa kurwisa COVID-19 uye 2 kuchengetedzwa.Zvakare, Daiichi Sankyo arikuvavarira mishonga yekudzivirira mRNA inogona kugoverwa mufiriji tembiricha (2-8°C)
Nguva yekutumira: Zvita-17-2022
